Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 31-40 of 43 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patientsColler, J.; Michalakas, J.; James, H.; Farquharson, A.; Colvill, J.; White, J.; Somogyi, A.
2012ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogeneticsBarratt, D.; Coller, J.; Hallinan, R.; Byrne, A.; White, J.; Foster, D.; Somogyi, A.
2004Large interindividual variability in the in vitro formation of tamoxifen metabolites related to the development of genotoxicityColler, J.; Krebsfaenger, N.; Klein, K.; Wolbold, R.; Nussler, A.; Neuhaus, P.; Zanger, U.; Eichelbaum, M.; Murdter, T.
2001Distribution of microsomal epoxide hydrolase in humans: An immunohistochemical study in normal tissues, and benign and malignant tumoursColler, J.; Fritz, P.; Zanger, U.; Siegle, I.; Eichelbaum, M.; Kroemer, H.; Murdter, T.
1999Flunitrazepam oxidative metabolism in human liver microsomes: involvement of CYP2C19 and CYP3A4Coller, J.; Somogyi, A.; Bochner, F.
2015Pharmacogenetics of opioid responseSomogyi, A.; Coller, J.; Barratt, D.
2010The combined impact of CYP2C19 and CYP2B6 pharmacogenetics on cyclophosphamide bioactivationHelsby, N.; Hui, C.; Goldthorpe, M.; Coller, J.; Soh, M.; Gow, P.; de Zoysa, J.; Tingle, M.
2014Pharmacogenomics of methadone maintenance treatmentSomogyi, A.; Barratt, D.; Ali, R.; Coller, J.
2012Inhibiting the TLR4-MyD88 signalling cascade by genetic or pharmacological strategies reduces acute alcohol-induced sedation and motor impairment in miceWu, Y.; Lousberg, E.; Moldenhauer, L.; Hayball, J.; Coller, J.; Rice, K.; Watkins, L.; Somogyi, A.; Hutchinson, M.
1997Association between CYP2C19 genotype and proguanil oxidative polymorphism.Coller, J.; Somogyi, A.; Bochner, F.